170 related articles for article (PubMed ID: 38007400)
1. Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer.
Arriola E; Jaal J; Edvardsen A; Silvoniemi M; Araújo A; Vikström A; Zairi E; Rodriguez-Mues MC; Roccato M; Schneider S; Ammann J
Oncologist; 2024 Apr; 29(4):e561-e569. PubMed ID: 38007400
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in participants receiving systemic anticancer treatment in clinical practice: protocol for an interventional, open-label, multicountry platform study (ORIGAMA).
Iivanainen S; Baird AM; Balas B; Bustillos A; Castro Sanchez AY; Eicher M; Golding S; Mueller-Ohldach M; Reig M; Welslau M; Ammann J
BMJ Open; 2023 Apr; 13(4):e063242. PubMed ID: 37076159
[TBL] [Abstract][Full Text] [Related]
3. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of weekly symptom telemonitoring in advanced lung cancer.
Yount SE; Rothrock N; Bass M; Beaumont JL; Pach D; Lad T; Patel J; Corona M; Weiland R; Del Ciello K; Cella D
J Pain Symptom Manage; 2014 Jun; 47(6):973-89. PubMed ID: 24210705
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
Sinclair P; Kable A; Levett-Jones T
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
[TBL] [Abstract][Full Text] [Related]
6. Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study.
Crafoord MT; Fjell M; Sundberg K; Nilsson M; Langius-Eklöf A
J Med Internet Res; 2020 Aug; 22(8):e17058. PubMed ID: 32663140
[TBL] [Abstract][Full Text] [Related]
7. PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.
Taylor AM; Chan DLH; Tio M; Patil SM; Traina TA; Robson ME; Khasraw M
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011395. PubMed ID: 33886122
[TBL] [Abstract][Full Text] [Related]
8. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
[TBL] [Abstract][Full Text] [Related]
9. Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.
Tran C; Dicker A; Leiby B; Gressen E; Williams N; Jim H
J Med Internet Res; 2020 Mar; 22(3):e12689. PubMed ID: 32209536
[TBL] [Abstract][Full Text] [Related]
10. THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.
Paladino AJ; Anderson JN; Krukowski RA; Waters T; Kocak M; Graff C; Blue R; Jones TN; Buzaglo J; Vidal G; Schwartzberg L; Graetz I
BMC Health Serv Res; 2019 Dec; 19(1):977. PubMed ID: 31856812
[TBL] [Abstract][Full Text] [Related]
11. Co-creation of an ICT-supported cancer rehabilitation application for resected lung cancer survivors: design and evaluation.
Timmerman JG; Tönis TM; Dekker-van Weering MG; Stuiver MM; Wouters MW; van Harten WH; Hermens HJ; Vollenbroek-Hutten MM
BMC Health Serv Res; 2016 Apr; 16():155. PubMed ID: 27121869
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel remote patient monitoring system: the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy.
Maguire R; Ream E; Richardson A; Connaghan J; Johnston B; Kotronoulas G; Pedersen V; McPhelim J; Pattison N; Smith A; Webster L; Taylor A; Kearney N
Cancer Nurs; 2015; 38(2):E37-47. PubMed ID: 24836956
[TBL] [Abstract][Full Text] [Related]
13. Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative.
Evans WK; Ung YC; Assouad N; Chyjek A; Sawka C
J Thorac Oncol; 2013 Jul; 8(7):876-82. PubMed ID: 23575416
[TBL] [Abstract][Full Text] [Related]
14. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.
Graetz I; McKillop CN; Stepanski E; Vidal GA; Anderson JN; Schwartzberg LS
J Cancer Surviv; 2018 Aug; 12(4):431-440. PubMed ID: 29492753
[TBL] [Abstract][Full Text] [Related]
15. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.
Benze G; Nauck F; Alt-Epping B; Gianni G; Bauknecht T; Ettl J; Munte A; Kretzschmar L; Gaertner J
Ann Palliat Med; 2019 Apr; 8(2):104-111. PubMed ID: 29156896
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy de-escalation using an
Pérez-García JM; Gebhart G; Ruiz Borrego M; Stradella A; Bermejo B; Schmid P; Marmé F; Escrivá-de-Romani S; Calvo L; Ribelles N; Martinez N; Albacar C; Prat A; Dalenc F; Kerrou K; Colleoni M; Afonso N; Di Cosimo S; Sampayo-Cordero M; Malfettone A; Cortés J; Llombart-Cussac A;
Lancet Oncol; 2021 Jun; 22(6):858-871. PubMed ID: 34019819
[TBL] [Abstract][Full Text] [Related]
17. User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients.
Prince RM; Soung Yee A; Parente L; Enright KA; Grunfeld E; Powis M; Husain A; Gandhi S; Krzyzanowska MK
J Med Internet Res; 2019 Mar; 21(3):e9958. PubMed ID: 30920373
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Diéras V; Miles D; Verma S; Pegram M; Welslau M; Baselga J; Krop IE; Blackwell K; Hoersch S; Xu J; Green M; Gianni L
Lancet Oncol; 2017 Jun; 18(6):732-742. PubMed ID: 28526536
[TBL] [Abstract][Full Text] [Related]
19. Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer.
Ganti AK; Lin CW; Yang E; Wong WB; Ogale S
J Manag Care Spec Pharm; 2022 Mar; 28(3):305-314. PubMed ID: 34913728
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
